September 27, 2019 / 6:11 PM / 16 days ago

BRIEF-FDA Approves Genentech's Rituxan (Rituximab) In Children With Two Rare Blood Vessel Disorders

Sept 27 (Reuters) - Genentech:

* FDA APPROVES GENENTECH’S RITUXAN (RITUXIMAB) IN CHILDREN WITH TWO RARE BLOOD VESSEL DISORDERS

* GENENTECH - FDA APPROVED RITUXAN COMBINED WITH GLUCOCORTICOIDS, FOR TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS & MICROSCOPIC POLYANGIITIS IN CHILDREN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below